Impella CP-Assisted Balloon Aortic Valvuloplasty in 2  High-Risk Patients

Mohsen  Mohandes; Mónica  Fuertes; Alberto  Pernigotti; Diego  Zambrano

doi:10.18502/jthc.v19i1.15616

Mohsen Mohandes Interventional Cardiology Unit, Cardiology Division, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Tarragona, Spain
Mónica Fuertes Interventional Cardiology Unit, Cardiology Division, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Tarragona, Spain
Alberto Pernigotti Interventional Cardiology Unit, Cardiology Division, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Tarragona, Spain.
Diego Zambrano Interventional Cardiology Unit, Cardiology Division, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Tarragona, Spain.

DOI: https://doi.org/10.18502/jthc.v19i1.15616

Keywords: Aortic stenosis; Valvular heart disease; Percutaneous coronary intervention

Abstract

Balloon aortic valvuloplasty (BAV) is a therapeutic option as palliative or bridging therapy in severe aortic stenosis, even
though it is a risky procedure, especially in patients with concomitant left ventricular dysfunction. The use of percutaneous ventricular assist devices, such as the Impella CP, in this scenario provides optimal circulatory support and considerably reduces the risk of the procedure. Two patients with severe aortic stenosis and left ventricular dysfunction underwent BAV with the support of the Impella-CP. The Impella CP provided adequate support in both high-risk patients and safely allowed BAV